|
1
|
Hayano K, Kulkarni NM, Duda DG, Heist RS
and Sahani DV: Exploration of imaging biomarkers for predicting
survival of patients with advanced non-small cell lung cancer
treated with antiangiogenic chemotherapy. AJR Am J Roentgenol.
206:987–993. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim A, Im M, Yim NH and Ma JY: Reduction
of metastatic and angiogenic potency of malignant cancer by
Eupatorium fortunei via suppression of MMP-9 activity and VEGF
production. Sci Rep. 4:69942014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai J, Li R, Xu X, Zhang L, Wu S, Yang T,
Fang L, Wu J, Zhu X, Li M and Huang Y: URGCP promotes non-small
cell lung cancer invasiveness by activating the NF-κB-MMP-9
pathway. Oncotarget. 6:36489–36504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu F and Zhu L: Expression of adiponectin
in non-small cell lung cancer and its relationship with MMP-9 and
angiogenesis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 40:579–584.
2015.(In Chinese). PubMed/NCBI
|
|
5
|
Lin X, Li HR, Lin XF, Yu ME, Tu XW, Hua
ZD, Lin M, Xu NL, Han LL and Chen YS: Silencing of Livin inhibits
tumorigenesis and metastasis via VEGF and MMPs pathway in lung
cancer. Int J Oncol. 47:657–667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Badrawy MK, Yousef AM, Shaalan D and
Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung
cancer patients and its relation to serum mmp-9 activity,
pathologic type, and prognosis. J Bronchology Interv Pulmonol.
21:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramanujum R, Lin YL, Liu JK and He S:
Regulatory expression of MMP-8/MMP-9 and inhibition of
proliferation, migration and invasion in human lung cancer A549
cells in the presence of HGF variants. Kaohsiung J Med Sci.
29:530–539. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsumoto Y, Zhang Q, Akita K, Nakada H,
Hamamura K, Tsuchida A, Okajima T and Furukawa K, Urano T and
Furukawa K: Trimeric Tn antigen on syndecan 1 produced by
ppGalNAc-T13 enhances cancer metastasis via a complex formation
with integrin α5β1 and matrix metalloproteinase 9. J Biol Chem.
288:24264–24276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu T, Xu Y, Huo J, Yang P, Gomez DR and
Liao Z: Incidental use of beta-blockers, serum VEGF, and their
association with disease outcome in patients with non-small-cell
lung cancer treated with definitive chemoradiation therapy. Int J
Radiat Oncol Biol Phys. 98:2452017. View Article : Google Scholar
|
|
10
|
Zhang H, Yun S, Batuwangala TD, Steward M,
Holmes SD, Pan L, Tighiouart M, Shin HJ, Koenig L, Park W, et al: A
dual-targeting antibody against EGFR-VEGF for lung and head and
neck cancer treatment. Int J Cancer. 131:956–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng H and Liu JF: Studies on the
relationship between P13K/AKT signal pathway-mediated MMP-9 gene
and lung cancer. Eur Rev Med Pharmacol Sci. 21:753–759.
2017.PubMed/NCBI
|
|
12
|
Farhat FS, Tfayli A, Fakhruddin N, Mahfouz
R, Otrock ZK, Alameddine RS, Awada AH and Shamseddine A:
Expression, prognostic and predictive impact of VEGF and bFGF in
non-small cell lung cancer. Crit Rev Oncol Hematol. 84:149–160.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerenidi T, Kazakou AP, Lada M, Tsilioni
I, Daniil Z and Gourgoulianis KI: Clinical significance of
circulating osteopontin levels in patients with lung cancer and
correlation with VEGF and MMP-9. Cancer Invest. 34:385–392. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H,
Cheng YW, Lai LC and Chang YH: Human papillomavirus up-regulates
MMP-2 and MMP-9 expression and activity by inducing interleukin-8
in lung adenocarcinomas. PLoS One. 8:e544232013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeo CD, Kim YA, Lee HY, Kim JW, Lee SH,
Kim SJ, Kwon SS, Kim YH and Kim SC: Inhibiting IGF-1R attenuates
cell proliferation and VEGF production in IGF-1R over-expressing
EGFR mutant non-small cell lung cancer cells. Exp Lung Res.
43:29–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng WJ, Zhang JQ, Wang BX, Pan HF, Lu MM
and Wang J: Prognostic value of matrix metalloproteinase 9
expression in patients with non-small cell lung cancer. Clin Chim
Acta. 413:1121–1126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan Z, Duan X, Cai H, Wang L, Li M, Qu J,
Li W, Wang Y and Wang J: Curcumin inhibits the invasion of lung
cancer cells by modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 signaling
pathway. Oncol Rep. 34:691–698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye HJ, Bai JJ, Guo PP, Wang W and Lin CS:
Propofol suppresses invasion of human lung cancer A549 cells by
down-regulating aquaporin-3 and matrix metalloproteinase-9. Nan
Fang Yi Ke Da Xue Xue Bao. 36:1286–1290. 2016.(In Chinese).
PubMed/NCBI
|
|
19
|
Xu L, Lina W and Xuejun Y: The diagnostic
value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
Open Med (Wars). 11:59–62. 2016.PubMed/NCBI
|
|
20
|
Lee CY, Shim HS, Lee S, Lee JG, Kim DJ and
Chung KY: Prognostic effect of matrix metalloproteinase-9 in
patients with resected Non-small cell lung cancer. J Cardiothorac
Surg. 10:442015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balla MM, Desai S, Purwar P, Kumar A,
Bhandarkar P, Shejul YK, Pramesh CS, Laskar S and Pandey BN:
Differential diagnosis of lung cancer, its metastasis and chronic
obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.
Sci Rep. 6:360652016. View Article : Google Scholar : PubMed/NCBI
|
